2016-11-14T14:03:19-06:00 2015-12-31 541029635 THOMPSON GREENSPON 4035 RIDGE TOP RD SUITE 700 FAIRFAX VA 22030 990 2015-01-01 263727917 REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION INC REAG 2028281204 1025 CONNECTICUT AVENUE NW NO 1000 WASHINGTON DC 20036 JUNE S WASSER MA EXECUTIVE DIRECTOR 2028281203 2016-11-11 1 RICHARD D CASTRO CPA P00367721 7033858888 2015 2017-02-10 21:41:12Z JUNE S WASSER MA 1025 CONNECTICUT AVENUE NW NO 1000 WASHINGTON DC 20036 3849081 0 X WWW.REAGANUDALL.ORG X 2009 MD THE FOUNDATIONS PRIMARY PURPOSE IS TO SUPPORT THE SCIENTIFIC MISSION OF THE US FOOD AND DRUG ADMINISTRATION BY ADVANCING REGULATORY SCIENCE AND RESEARCH. THE FOUNDATION PROVIDES A UNIQUE OPPORTUNITY TO BRING ALL PARTIES TO THE TABLE TO WORK TOGETHER TO CREATE NEW SCIENCE. 15 15 8 0 0 0 4226045 3849070 0 0 8 11 0 0 4226053 3849081 0 0 0 0 715022 807223 0 0 15106 3238259 3708974 3953281 4516197 272772 -667116 2248205 1384427 928156 731494 1320049 652933 X THE FOUNDATION'S PRIMARY PURPOSE IS TO ADVANCE THE MISSION OF THE FOOD AND DRUG ADMINISTRATION TO MODERNIZE MEDICAL, VETERINARY, FOOD, FOOD INGREDIENT, AND COSMETIC PRODUCT DEVELOPMENT, ACCELERATE INNOVATION, AND ENHANCE PRODUCT SAFETY PURSUANT TO SECTION 770 OF THE FEDERAL FOOD, DRUG, AND COSMETIC ACT. THE FOUNDATION'S CURRENT PROJECTS INCLUDE THE CRITICAL PATH TO TUBERCULOSIS DRUG REGIMENS PROJECT (CPTR), THE INNOVATION IN MEDICAL EVIDENCE DEVELOPMENT AND SURVEILLANCE (IMEDS), THE BIG DATA FOR PATIENTS (BD4P), THE ALZHEIMER'S ASSOCIATION FELLOWSHIP (AA) AND THE HEALTH OUTCOME OF INTEREST IN SECONDARY OR AUTOMATED DATA SOURCES PROJECT (HOI). 0 0 4137661 LED AND COLLABORATED ON PROJECTS TO ADVANCE THE SCIENTIFIC MISSION OF THE FDA. 4137661 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 8 1 0 0 0 0 0 0 0 0 X 15 15 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 0 0 0 0 0 X THE FOUNDATION 2028281205 1025 CONNECTICUT AVENUE NW SUITE WASHINGTON DC 20036 MARK C ROGERS MD MBA CHAIRMAN 4.00 X X 0 0 0 ELLEN V SIGAL PHD VICE CHAIRMAN 4.00 X X 0 0 0 GEORGES C BENJAMIN MD TREASURER 4.00 X X 0 0 0 KAY HOLCOMBE SECRETARY 4.00 X X 0 0 0 PAMELA G BAILEY DIRECTOR 4.00 X 0 0 0 ALLAN COUKELL DIRECTOR 4.00 X 0 0 0 HELEN DARLING DIRECTOR 4.00 X 0 0 0 SALLY J GREENBERG JD DIRECTOR 4.00 X 0 0 0 GARRY NEIL MD DIRECTOR 4.00 X 0 0 0 RICHARD L SCHILSKY MD DIRECTOR 4.00 X 0 0 0 DIANA ZUCKERMAN PHD DIRECTOR 4.00 X 0 0 0 TADATAKA YAMADA MD DIRECTOR 4.00 X 0 0 0 SHERINE E GABRIEL MD MSC DIRECTOR 4.00 X 0 0 0 MARK MCCLELLAN MD PHD DIRECTOR 4.00 X 0 0 0 ELIZABETH MCGLYNN PHD DIRECTOR 4.00 X 0 0 0 ROBERT TIJAN DIRECTOR 4.00 X 0 0 0 NICK VALERIANI DIRECTOR 4.00 X 0 0 0 JANE REESE-COULBOURNE EXECUTIVE DIRECTOR 40.00 X 150000 0 19390 SUSAN GRUBER SENIOR DIRECTOR, IMEDS MET 40.00 X 126466 0 10756 276466 0 30146 2 0 1 0 EPHIR INC 145 TREMONT STREET BOSTON MA 02111 INFORMATION TECHNOLOGY 666000 TROY MCCALL 104 GORGE COURT CARY NC 27518 CONSULTING 342518 TRUVEN HEALTH ANALYTICS 777 E EISENHOWER PKWY ANN ARBOR MI 48108 CONSULTING 322321 AMAZON WEB SERVICES 1 CENTERPOINT BLVD NEW CASTLE DE 19720 WEB SERVICES 309308 BRIGHAM & WOMEN HOSPITAL PO BOX 3887 BOSTON MA 02241 CONSULTING 297813 5 3849070 3849070 11 11 3849081 0 0 11 169390 137894 28796 2700 637833 601670 36163 3167428 2998836 157348 11244 137127 80937 56190 56973 56973 64686 59265 5205 216 185094 169580 14895 619 97666 89479 7860 327 4516197 4137661 363430 15106 443562 1172430 25213 25224 1679448 13929 73611 150120 47422 42298 8771 5124 17600 17600 2248205 1384427 673095 549628 255061 181866 928156 731494 X 11692 1320049 641241 1320049 652933 2248205 1384427 -667116 0 X X 0 1 X 1 0 X 1067165 911268 4126161 4226045 3848959 14179598 1067165 911268 4126161 4226045 3848959 14179598 7079908 7099690 160 45 8 11 224 14179822 0.50070 0.46730 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 13636 8512 5124 33786 33786 0 5124 GRANT REFUND PAYABLE 181866 181866 X 4044261 195180 195180 3849081 0 3849081 4711377 195180 195180 4516197 0 4516197 PART X, LINE 2: THE FOUNDATION HAS NO UNCERTAIN TAX POSITIONS THAT QUALIFY FOR EITHER RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS AND NO INTEREST AND PENALTIES HAVE BEEN RECORDED IN THE ACCOMPANYING FINANCIAL STATEMENTS RELATED TO UNCERTAIN TAX POSITIONS. X 0 0 0 0 0 0 0 0 0 JANE REESE-COULBOURNE EXECUTIVE DIRECTOR 150000 0 0 0 0 0 0 0 19390 0 169390 0 0 0 FORM 990, PART VI, SECTION B, LINE 11 AFTER THE FORM 990 IS PREPARED BY THE INDEPENDENT ACCOUNTANTS IT IS REVIEWED BY THE EXECUTIVE DIRECTOR AND THE TREASURER BEFORE BEING FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST POLICY COVERS ALL MEMBERS OF THE BOARD, ITS COMMITTEES, BUSINESS ASSOCIATES, AND FOUNDATION STAFF AND THEIR IMMEDIATE FAMILIES. IT IS MONITORED BY ANNUAL WRITTEN INFORMATION STATEMENTS WHICH ARE REVIEWED AND MAINTAINED BY THE BOARD AND GENERAL COUNSEL. THE ENTIRE BOARD REVIEWS EACH TRANSACTION TO COME BEFORE THE BOARD FOR POTENTIAL OR ACTUAL CONFLICTS OF INTEREST. IF POTENTIAL OR ACTUAL CONFLICTS (PAST, PRESENT OR FUTURE) ARE IDENTIFIED, THE PERSON DETERMINED TO HAVE A CONFLICT IS RECUSED FROM DELIBERATIONS AND VOTING. THE IDENTIFIED CONFLICTS OF INTEREST AND APPROPRIATE RECUSALS ARE DOCUMENTED IN THE MINUTES OF EACH BOARD OR COMMITTEE MEETING. FORM 990, PART VI, SECTION C, LINE 19 THE FOUNDATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC ON THEIR WEBSITE. FORM 990, PART XII, LINE 2C: THE AUDIT COMMITTEE SELECTS THE INDEPENDENT ACCOUNTING FIRM AND REVIEWS AND APPROVES ALL FINANCIAL STATEMENTS.